Ian Alberts
Overview
Explore the profile of Ian Alberts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
911
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al Aameri R, Alanisi E, Al Sallami D, Alberts I, Tischkau S, Rybak L, et al.
Front Immunol
. 2025 Mar;
16:1470625.
PMID: 40061942
Cisplatin is a chemotherapy drug used to treat different solid tumors, including ovarian, bladder, lung, and head and neck cancers. One of its significant side effects is ototoxicity, especially when...
2.
Li J, Chen B, Li Z, Wang Y, Alberts I, Sun K, et al.
Brain Behav
. 2024 Nov;
14(11):e70121.
PMID: 39529258
Background And Aims: Rhynchophylline (RHY) can alleviate some cognitive flexibility impairment and stereotyped behavior for attention-deficit hyperactivity disorder (ADHD) and Tourette syndrome (TS) patients as one of a key extract...
3.
Mingels C, Chung K, Pantel A, Rominger A, Alberts I, Spencer B, et al.
Semin Nucl Med
. 2024 Sep;
55(1):21-30.
PMID: 39341688
Long-axial field-of-view (LAFOV) systems have changed the field of molecular imaging. Since their introduction, many PET centers have installed these next-generation digital systems to provide more detailed imaging and acquire...
4.
Abdollahi H, Yousefirizi F, Shiri I, Brosch-Lenz J, Mollaheydar E, Fele-Paranj A, et al.
Theranostics
. 2024 Jul;
14(9):3404-3422.
PMID: 38948052
Radiopharmaceutical therapy (RPT) is a rapidly developing field of nuclear medicine, with several RPTs already well established in the treatment of several different types of cancers. However, the current approaches...
5.
Jiang J, Shi R, Lu J, Wang M, Zhang Q, Zhang S, et al.
Neuroimage
. 2024 Mar;
291:120593.
PMID: 38554780
Objective: The conventional methods for interpreting tau PET imaging in Alzheimer's disease (AD), including visual assessment and semi-quantitative analysis of fixed hallmark regions, are insensitive to detect individual small lesions...
6.
Mingels C, Weissenrieder L, Zeimpekis K, Sari H, Nardo L, Caobelli F, et al.
Eur J Nucl Med Mol Imaging
. 2024 Feb;
51(7):2036-2046.
PMID: 38383743
Purpose: High blood glucose (hBG) in patients undergoing [F]FDG PET/CT scans often results in rescheduling the examination, which may lead to clinical delay for the patient and decrease productivity for...
7.
Mei R, Pyka T, Sari H, Fanti S, Afshar-Oromieh A, Giger R, et al.
Eur J Nucl Med Mol Imaging
. 2023 Dec;
51(5):1436-1443.
PMID: 38095670
Purpose: To evaluate the utility of long duration (10 min) acquisitions compared to standard 4 min scans in the evaluation of head and neck cancer (HNC) using a long-axial field-of-view...
8.
Cumming P, Dias A, Gormsen L, Hansen A, Alberts I, Rominger A, et al.
EJNMMI Res
. 2023 Nov;
13(1):104.
PMID: 38032409
Background: Until recently, quantitation of the net influx of 2-[F]fluorodeoxyglucose (FDG) to brain (K) and the cerebrometabolic rate for glucose (CMR) required serial arterial blood sampling in conjunction with dynamic...
9.
Mingels C, Sari H, Gozlugol N, Bregenzer C, Knappe L, Krieger K, et al.
Eur J Nucl Med Mol Imaging
. 2023 Sep;
51(2):422-433.
PMID: 37740742
Purpose: Inflamed, prone-to-rupture coronary plaques are an important cause of myocardial infarction and their early identification is crucial. Atherosclerotic plaques are characterized by overexpression of the type-2 somatostatin receptor (SST)...
10.
Rybak L, Alberts I, Patel S, Al Aameri R, Ramkumar V
Expert Opin Drug Metab Toxicol
. 2023 Sep;
19(9):635-652.
PMID: 37728555
Introduction: Cisplatin is a very effective chemotherapeutic agent against a variety of solid tumors. Unfortunately, cisplatin causes permanent sensorineural hearing loss in at least two-thirds of patients treated. There are...